Generic Emend

Generic Emend will not be available in the United States until 2011, at the earliest. This is because the medication is currently under the protection of a patent that prevents any generic versions from being manufactured. Unless certain circumstances arise to extend this exclusivity period, generic Emend products are expected to become available in January 2011.

 

Emend Generic: An Overview

Emend® (aprepitant) is a prescription medication used for the prevention of nausea and vomiting caused by chemotherapy or surgery.
 
Emend is made by Merck & Co., Inc. It is currently under the protection of a patent that prevents any generic Emend from being manufactured in the United States.
 

When Will Generic Emend Be Available?

The first patent for Emend currently expires in January 2011. This is the earliest possible date that a generic version of Emend could become available. However, there are other circumstances that could come up to extend the exclusivity period of Emend beyond 2011. This could include such things as other patents for specific Emend uses or lawsuits. Once Emend goes off patent, other companies may begin manufacturing a generic Emend drug.
 

Affording Emend

Emend is a very expensive medication (as are many new nausea and vomiting medications). If you do not have insurance coverage (or if your insurance does not cover Emend) and you cannot afford Emend, you may qualify to receive free Emend from Merck. Ask your healthcare provider about the Emend patient assistance program.
 
Add this article to your Favorites     Email this article     Print
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD;